Standout Papers
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet (2009)
- Acute Myeloid Leukemia (2015)
- Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia (2000)
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2008)
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia (2008)
- Acute myeloid leukaemia (2006)
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (2018)
- Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia (2004)
- Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances (1997)
- Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm (2002)
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet (2008)
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission (2009)
- Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations (2005)
- V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia (2002)
- High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia (2009)
- IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication (2010)
- Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia (2022)
- Towards precision medicine for AML (2021)
Immediate Impact
8 by Nobel laureates 10 from Science/Nature 106 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Acute myeloid leukaemia
2023 Standout
Works of Hartmut Döhner being referenced
Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia
2022 Standout
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hartmut Döhner | 20674 | 18626 | 17222 | 644 | 44.0k | |
| Donna Neuberg | 12077 | 9201 | 14045 | 713 | 45.2k | |
| Francis J. Giles | 20046 | 15414 | 14728 | 778 | 41.0k | |
| Clara D. Bloomfield | 28029 | 11828 | 17444 | 400 | 42.0k | |
| Brian Druker | 29898 | 21325 | 17055 | 597 | 54.0k | |
| Moshe Talpaz | 28654 | 22419 | 10816 | 765 | 44.0k | |
| Daniel Catovsky | 14409 | 19063 | 7116 | 530 | 34.7k | |
| Michael Andreeff | 15751 | 10107 | 25506 | 987 | 47.2k | |
| Guillermo Garcia‐Manero | 29771 | 14343 | 17388 | 1.5k | 42.9k | |
| Frederick R. Appelbaum | 30424 | 8780 | 9672 | 594 | 41.8k | |
| William G. Wierda | 10760 | 17768 | 8334 | 821 | 30.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...